Researchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children, the elderly and other immunocompromised ...
Jun 1, 2024
0
21
An international, multisite Phase III trial, co-led by a University of Cincinnati researcher, has found that a Parkinson's disease medication delivered through an infusion pump is safe and effective at reducing symptoms ...
Mar 18, 2024
0
38
Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects ...
Dec 13, 2023
0
22
People who drink more than three liters of fluid a day may be suffering from a rare hormone deficiency. For many, however, it is just a harmless habit. Failing to differentiate the two correctly can be fatal, so researchers ...
Nov 16, 2023
0
56
Another at-home treatment option for the flu and other respiratory illnesses is closer to becoming a reality, thanks to new research that found inhaled, monoclonal antibodies against SARS-CoV-2 significantly reduced COVID-19 ...
Nov 7, 2023
0
34
Gastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death. The reason for this is late diagnosis coupled with rapid spread of tumor cells in the body.
May 8, 2023
0
29
Scientists are pursuing injections or intravenous infusions of broadly neutralizing HIV antibodies (bNAbs) as a strategy for preventing HIV infection. This technique, called passive immunization, has been shown to protect ...
Aug 13, 2014
0
0
OptumHealth Care Solutions, a subsidiary of UnitedHealth Group, joined the manufacturer and the U.S. Food and Drug Administration in recalling an infusion pump system that has killed at least one patient.
May 31, 2024
0
0
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials.
Apr 24, 2024
0
0
Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.
Apr 13, 2024
0
4
